This document discusses treatment for myocardial infarction (heart attack). It covers reperfusion therapy including thrombolysis and percutaneous coronary intervention (PCI). It notes contraindications for thrombolysis therapy and emphasizes that time is critical, with mortality reduction seen in patients receiving thrombolysis within 1-12 hours of symptoms starting. It also discusses antiplatelet therapy drugs like aspirin, ticlopidine, clopidogrel, abciximab, and tirofiban that are used to reduce reinfarction, stroke and death following a heart attack.
